Genmab Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and Euro
25/5 23:10
Media Release COPENHAGEN, Denmark ; May 25 , 20 2 3 Oral presentation s will highlight epcoritamab - bysp in combination with rituximab - lenalidomide (R2) in high-risk follicular lymphoma P oster presentations will highlight epcoritamab in lymphoma across multiple lines of therapy and histolog ies...